21.03.2013 Views

Lower GI Endoscopy Basic Skills Training Resource Folder

Lower GI Endoscopy Basic Skills Training Resource Folder

Lower GI Endoscopy Basic Skills Training Resource Folder

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Lower</strong> <strong>GI</strong> <strong>Endoscopy</strong> <strong>Basic</strong> <strong>Skills</strong> <strong>Training</strong> <strong>Resource</strong> <strong>Folder</strong><br />

Background 2<br />

E-portfolio/JAG certification for the lower <strong>GI</strong> basic skills course 3<br />

What is the JETS e-portfolio 3<br />

How do I register with the e-portfolio? 3<br />

Why use the e-portfolio? 3<br />

JAG certification 3<br />

Eligibility criteria for colonoscopy 4<br />

Provisional Certification 4<br />

Full Certification 4<br />

Polypectomy 5<br />

Numbers 5<br />

Complications 5<br />

Informed Consent in <strong>Endoscopy</strong>. 6<br />

Indications for Colonoscopy 8<br />

Diagnostic 8<br />

Screening 8<br />

Surveillance 8<br />

Contraindications to <strong>Lower</strong> <strong>GI</strong> <strong>Endoscopy</strong> 9<br />

Absolute contraindications 9<br />

Relative contraindications 9<br />

General patient comorbidity factors 9<br />

Drug therapy 9<br />

Specific contraindications to lower <strong>GI</strong> endoscopy 9<br />

Summary 10<br />

Complications of <strong>Lower</strong> <strong>GI</strong> endoscopy 11<br />

Procedure Related complications 11<br />

Complications related to <strong>Endoscopy</strong>: General Considerations 13<br />

Risk vs benefit 13<br />

Sedation (see below) 13<br />

The risks of infection 13<br />

Risks of bleeding 13<br />

Anticoagulation Issues 13<br />

Post procedure advice/ contact details 13<br />

Clinical Governance 14<br />

Key Messages 14<br />

Diathermy 15<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 1


How diathermy works 15<br />

Monopolar diathermy 16<br />

Bipolar diathermy 16<br />

Precautions when using diathermy 18<br />

Further Reading 19<br />

Endoscope Design and Function 20<br />

Overview 20<br />

Head of instrument 20<br />

Channels 21<br />

Decontamination of <strong>GI</strong> endoscopes 22<br />

Potential advantages and complications of oral bowel cleansing agents 23<br />

Suggested Background reading for <strong>Basic</strong> lower <strong>GI</strong> endoscopy course 24<br />

Suggested Website <strong>Resource</strong>s 25<br />

Background<br />

This folder was created in a collective project by the regional endoscopy training centre in the UK. It<br />

constitutes some basic background knowledge relevant to modern endoscopic practice. It is not intended<br />

to be exhaustive or comprehensive, but merely to act as a reference resource to support endoscopy<br />

training both on the JAG endoscopy courses and at base hospitals.<br />

Contributions from:<br />

John Anderson<br />

Paul Dunckley<br />

Mark Feeney<br />

Rachael Hodson<br />

Roger Leicester<br />

Brian McKaig<br />

Paul O’Toole<br />

Richard Robinson<br />

John Silcock<br />

John Todd<br />

Maggie Vance<br />

John Anderson<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 2


E-portfolio/JAG certification for the lower <strong>GI</strong> basic skills course<br />

Paul Dunckley, Gloucestershire <strong>Training</strong> Centre<br />

What is the JETS e-portfolio<br />

The JETS e-portfolio is JAG’s logbook for trainees in endoscopy. It is available for all trainees. It has been<br />

designed to make it as easy as possible for trainees to submit their key endoscopic data and provides<br />

trainees with all the performance outputs that they need to chart their competence progression and<br />

then apply for JAG certification. The e-portfolio can be accessed via the JETS website (www.jets.nhs.uk).<br />

More detailed information about the e-portfolio can be found on the JAG website<br />

(www.thejag.org.uk/<strong>Training</strong>forEndoscopists/eportfolio.aspx).<br />

How do I register with the e-portfolio?<br />

In order to start using the JETS e-portfolio, the trust e-portfolio administrator or training lead will need<br />

to add a trainee to their system. The trainee will need to provide them with their GMC number and<br />

personal e-mail address. Once added to the trust system they will be able to log all of their endoscopic<br />

procedures.<br />

Why use the e-portfolio?<br />

The e-portfolio provides the user with the following benefits:<br />

o A simple way of logging endoscopic experience<br />

o It provides all key summary performance data in output tables<br />

o Online DOPS assessments<br />

o Generates a personal development plan through DOPS assessments<br />

o Provides output graphs of progression in DOPS scores<br />

o Submitting data to the e-portfolio is a pre-requisite for JAG certification application<br />

JAG certification<br />

In order to practice endoscopy independently within a JAG accredited endoscopy unit, trainees will need<br />

to be certified by JAG in each procedure. Once trainees have achieved the necessary eligibility criteria<br />

(table 1), they will need to have a summative assessment (see<br />

http://www.thejag.org.uk/<strong>Training</strong>forEndoscopists/<strong>Endoscopy</strong>Trainees/TraineeCertification/Summative<br />

Assessments.aspx). This is co-ordinated through the JETS e-portfolio as is the submission of your<br />

application to the JAG office.<br />

For colonoscopy, evidence of competence in polypectomy will also be required before certification is<br />

granted. There is a two stage certification process. Initially trainees will be provisionally certified which<br />

means that they have demonstrated competence in diagnostic colonoscopy and removing smaller<br />

(1cm) polyps.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 3


Eligibility criteria for colonoscopy<br />

Eligibility criteria are shown in the tables below. The previous 3 months of data on the e-portfolio will be<br />

used to calculate the eligibility criteria.<br />

Provisional Certification<br />

Eligibility criteria Requirement Notes<br />

Caecal intubation rate >90%<br />

Formative DOPS scores >90% “3”s and “4”s A minimum of 10 DOPS required<br />

Formative DOPyS scores* >90% “3”s and “4”s Last 4 DOPyS scores, or last 3 months, whichever is greater<br />

Unassisted physically >90% I.e. the trainer does not take the scope for >90% of procedures<br />

<strong>Basic</strong> skills lower <strong>GI</strong> course Attended<br />

* polypectomy level 1<br />

Full Certification<br />

Eligibility criteria Requirement Notes<br />

Caecal intubation rate >90%<br />

Polyp detection and removal >10%<br />

Serious complications 90% “3”s and “4”s Last 4 DOPyS scores, or last 3 months, whichever is<br />

greater<br />

** Serious complications defined as death, perforation, significant bleeding requiring > 2 unit<br />

transfusion, post-procedure hospital stay of > 24 hours (related to procedure) or admission to<br />

hospital due to a complication of the procedure following discharge from endoscopy unit. This figure is<br />

calculated over the preceding year.<br />

*** - Under 70yrs < 5mgs midazolam<br />


Polypectomy<br />

Trainees will be expected to have been assessed at their polypectomy skills. When a polyp is identified,<br />

the trainer should join the trainee, observe/train on polypectomy followed by the completion of a<br />

DOPyS. A DOPyS is a DOPS form created specifically to assess polypectomy. It can be found in the DOPS<br />

sections of the JETS e-portfolio. DOPyS can be completed during either flexible sigmoidoscopies or<br />

colonoscopies. Polypectomy level 1 denotes all polyps less than 1cm in size, level 2 denotes all polyps<br />

greater than 1cm in size.<br />

Numbers<br />

The recommended numbers of procedures by JAG for each trainee applying for provisional certification<br />

is 200. For full colonoscopy certification, it is 300. Number of procedures is no longer a mandatory<br />

requirement for application. However, only under exceptional circumstances will trainees be granted<br />

provisional or full certification if they have performed significantly fewer than the recommended<br />

number of procedures since all common pathology and unusual anatomy may not be encountered with<br />

lower procedural experience. .JAG reviewers may seek additional evidence of competence and evidence<br />

of support from their trainer in this situation.<br />

Complications<br />

Trainees with just 2 serious complications may find that they have complication rates of >0.5%. If a<br />

serious complication occurs, the JETS e-portfolio will automatically ask the trainee to provide details of<br />

the event, what the trainee did and what the trainee learnt from that event. These boxes will have to be<br />

signed off by one of their trainers. These boxes will be assessed by the JAG reviewer on application to<br />

ensure that sufficient learning was gained from each episode. It will be at the discretion of the JAG<br />

reviewer whether or not to allow certification based on the information provided.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 5


Informed Consent in <strong>Endoscopy</strong>.<br />

Maggie Vance, St Mark’s Hospital<br />

Definition<br />

Consent is the process of confirming a patient’s agreement to permit a health care professional to<br />

provide care. 1<br />

The Department of Health (DH) has published a reference guide for clinicians on informed consent. 2 A<br />

key part of consent is assessing the patient’s capacity to give consent for a procedure. Please refer to the<br />

above DH publication for guidance on mental capacity.<br />

The BSG has written a specific guideline concerning valid informed consent in <strong>Endoscopy</strong>, accessed on<br />

the following website. This is required reading for all endoscopy department staff involved in the<br />

process of informed consent. The guidance provides information on who can consent, who can provide<br />

consent and the information that should be provided during the consent process.<br />

In summary the BSG recommends that all flexible endoscopic procedures require written consent. As<br />

part of informed consent, health care professionals must provide patients with accurate information<br />

about the reasons for the procedure, the potential risks, benefits and alternatives of the procedure to<br />

enable the patient to make an informed decision as to whether they should undergo endoscopy. A<br />

crucial part of the consent process is to check the patient’s understanding of the information given. The<br />

following information should be provided concerning the procedure to enable the patient to make an<br />

informed decision -<br />

• Explanation - of the procedure<br />

• Motivation - why this procedure<br />

• Benefits - expected outcomes<br />

• Risks & complications - rare and serious and how these would be managed<br />

• Alternatives available<br />

• Consequences - of doing nothing<br />

• Side Effects - frequent and temporary<br />

• Sedation<br />

• Taking and retention of specimens<br />

• Taking of photographic or video record<br />

• The skilled supervision of and presence of any trainees<br />

• The use of any experimental technique<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 6


References<br />

1. Guidance for Obtaining a Valid Consent for Elective Endoscopic Procedures (2008). www.bsg.org.uk.<br />

Accessed April 2012<br />

2. Reference guide to consent for examination or treatment, second edition 2009. DoH.<br />

http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/D<br />

H_103643. Accessed April 2012.<br />

Further reading on the subject can be found on the following publications.<br />

General Medical Council (2007) Consent: patients and doctors making<br />

Decisions together. A draft for consultation. May-August 2007<br />

Mental Capacity Act (2005)<br />

Human Rights Act (1998)<br />

Department of Health (2009) Reference guide to consent for examination<br />

or treatment<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 7


Indications for Colonoscopy<br />

Richard Robinson, Leicester <strong>Training</strong> Centre<br />

NB: Colonoscopy is NOT the only test for the indications listed below: it may not always be the most<br />

appropriate or timely test (see below)<br />

Diagnostic<br />

1. Rectal bleeding<br />

2. Iron deficiency anaemia (confirm with MCV 60y, (or > 40y if associated with rectal bleeding)<br />

Screening<br />

1. National Bowel Cancer Screening Programme<br />

2. Family History (including familial polyp syndromes)<br />

Surveillance<br />

Surveillance for neoplasia in patients at risk (see family cancer syndromes)<br />

o previous polyp / cancer<br />

o IBD<br />

o uretero-sigmoidoscopy<br />

o acromegaly<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 8


Contraindications to <strong>Lower</strong> <strong>GI</strong> <strong>Endoscopy</strong><br />

Brian McKaig, Wolverhampton <strong>Training</strong> Centre<br />

These can be considered in 2 categories<br />

Absolute contraindications<br />

Relative contraindications<br />

Absolute contraindications<br />

1. Withdrawal of consent by competent patient.<br />

2. Endoscopist not accredited / incompetent to perform procedure.<br />

This is critically important. As an endoscopist it is essential that you (independently) undertake<br />

only those procedures in which you have been deemed competent. This includes competency in<br />

any therapy (eg polypectomy, dye spray) which is likely to be encountered during the procedure.<br />

3. Uncooperative patient, unable to be safely sedated.<br />

Relative contraindications<br />

1. Relative contraindications are those situations in which risk is substantially increased.<br />

2. There are many factors which influence the risks vs benefits of lower <strong>GI</strong> endoscopy.<br />

3. Every procedure in every patient must be assessed with regard to risks & benefits as this will<br />

vary between patients and will be influenced by the urgency of the intended endoscopic<br />

intervention.<br />

4. It is vitally important to optimise the patient’s condition prior to undertaking any form of<br />

endoscopy. Patients with ASA 3 or higher are at particular risk<br />

5. If there is any doubt as to whether L<strong>GI</strong> endoscopy is contraindicated then senior advice should<br />

be sought at the earliest opportunity.<br />

General patient comorbidity factors<br />

Respiratory: COPD / hypoxia / infection<br />

Cardiac: unstable IHD / acute MI<br />

Neurological: CVA, any condition resulting in reduced GCS<br />

Cardiovascular instability: hypotension and uncontrolled hypertension<br />

Electrolyte abnormalities / hypo & hyperglycaemia<br />

Frailty<br />

Drug therapy<br />

Anticoagulation/antiplatelet therapy: BSG guideline anticoagulant-antiplatelet-therapy<br />

Specific contraindications to lower <strong>GI</strong> endoscopy<br />

Acute severe colitis / toxic megacolon<br />

Acute diverticulitis<br />

Acute abdomen<br />

Perforated viscus<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 9


Summary<br />

Most contraindications to lower <strong>GI</strong> endoscopy are relative and need to be considered with<br />

current clinical situation<br />

Remember that colonoscopy involves bowel prep, sedation as well as the procedure/therapy<br />

If in doubt, seek senior advice<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 10


Complications of <strong>Lower</strong> <strong>GI</strong> endoscopy<br />

Mark Feeney, Torbay <strong>Training</strong> Centre<br />

Procedure Related complications<br />

Perforation<br />

Perforation during diagnostic colonoscopy in a healthy bowel is an unusual occurrence. Most<br />

perforations occur as a result of therapy such as polypectomy or due to a weakness in the bowel wall<br />

e.g. diverticular change or severe colitis. Factors associated with a poor outcome after perforation<br />

include (a) increasing age; (b) significant co-morbidity; (c) delayed recognition of perforation; (d)<br />

delayed treatment; (e) poor bowel preparation.<br />

Bleeding<br />

There is approximately 1% risk of post-polypectomy bleeding. It may be immediately apparent and<br />

allows the endoscopist to take immediate action to achieve haemostasis, or admit the patient to<br />

consider other treatment +/- surgery. Delayed bleeds are a well recognised complication of polypectomy<br />

and can occur up to 10 days post procedure. It is important that the patient is aware of this possibility<br />

and has a plan to seek reassessment urgently if a late bleed occurs. Some polyps are particularly high<br />

risk for bleeding e.g. large stalk in a position with poor access. The endoscopist should only attempt<br />

procedures within their personal range of expertise. A full range of equipment should be available to<br />

stop bleeding e.g. clips and loops, the assisting staff must be familiar with their use. (See anticoagulation<br />

issues below).<br />

Missed pathology<br />

The possibility of missed pathology can be classified as a complication of colonoscopy. Some studies<br />

suggest a miss rate of significant pathology in up to 5 % of cases. This should be discussed at during the<br />

consent process. The patient should be told that even after a normal colonoscopy they should not<br />

ignore rectal bleeding or subsequent change in bowel habit; they should be reassessed.<br />

Bowel Preparation<br />

Bowel preparation can cause electrolyte imbalances and cause renal injury especially when phosphate<br />

based products are used (Picolax). Recognised effects include hypovolaemia, hyponatraemnia ,<br />

hypokalaemia, hypocalcaemia and hyperphosphataemia. Frail patients may develop postural<br />

hypotension related to bowel prep and this, may increase their risk of falling. To minimise these side<br />

effects bowel preparation should be prescribed by a clinician who can assess each patient individually.<br />

The large volume non-absorbed iso-osmotic agents such as Klean prep are less likely to cause electrolyte<br />

imbalance and fluid shifts but are less well tolerated by some patients<br />

Guidelines for the prevention and management of complications of gastrointestinal endoscopy. October<br />

2006 Jonathon Green for the BSG http://www.bsg.org.uk<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 11


Example of algorithm to guide management of a complication – Perforation<br />

Communication with<br />

patient/family<br />

NB note keeping<br />

Soon<br />

Emergency<br />

surgery<br />

Is Immediate<br />

endoscopic<br />

treatment possible?<br />

Define extent of<br />

perforation: CT<br />

Urgent<br />

Surgical<br />

Review<br />

Clinical Symptoms<br />

of a perforation<br />

Conservative<br />

management<br />

Stabilize the patient<br />

i.v fluids, Pain relief<br />

i.v antibiotics, NBM<br />

Antibiotics<br />

Immediate<br />

Admit to high<br />

dependency area<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 12


Complications related to <strong>Endoscopy</strong>: General Considerations<br />

Risk vs benefit<br />

The risk of a complication depends on the pathology encountered and the procedure undertaken. The<br />

outcome of any complication is greatly influenced by the underlying condition of the patient and their<br />

co-morbidities. Before any invasive endoscopic test is undertaken consideration should be given to the<br />

use of less invasive tests; could another test/ procedure provide similar information with less risk? The<br />

examination of risk benefit is particularly important when considering therapeutic intervention.<br />

Therapeutic procedures, especially involving abnormal tissue, have the greatest risk of significant<br />

complications. The clinician must be sure that the potential benefit of the intervention is greater than<br />

the risk; this will depend on an assessment for each individual patient. To achieve good decision making<br />

and allow an appropriate consent the clinician must have a thorough knowledge of complications and<br />

good clinical judgement to assess each case individually.<br />

Sedation (see below)<br />

Both opiates and benzodiazepines can lead to respiratory depression and their effects are synergistic.<br />

(1)Pre-oxygenation will reduce risks, (2)Titrate doses of drugs, (3) Give opioid first, (4) continuous<br />

Oxygen saturation monitoring during the procedure and in recovery.<br />

The risks of infection<br />

These risks are relatively low. Units should follow the decontamination guidelines.The indications for<br />

prophylactic antibiotics are quite selective and are available at BSG guidelines.<br />

Risks of bleeding<br />

Diagnostic biopsies unlikley to cause significant bleeding unless clotting deranged. Biopsies can usually<br />

be safely undertaken with platelet counts > 20,000 and an INR < 2.5 .<br />

Anticoagulation Issues<br />

If more invasive procedures are planned then the management of anticoagulation should be reviewed<br />

several weeks before any elective procedure. Decisions will depend on the risk of the procedure and the<br />

risks related to interrupting anticoagulation. Warfarin may need to be stopped and heparin considered if<br />

the indication for ongoing anti-coagulatuion is essential. Clopidogrel can cause a significant increased<br />

risk of bleeding. Discussion with other clinicians e.g. haematologist and cardiologist may be essential to<br />

make the most appropriate and safe plan. See BSG Guidelines Veitch et al.<br />

Post procedure advice/ contact details<br />

After the procedure before discharge from the unit the patient should be told what to do if they have<br />

any problems e.g. bleeding or pain. They should be given a sheet explain how to seek advice by<br />

telephone or if necessary reassessment (attend with a copy of their endoscopy report). It is essential to<br />

have a system to identify late complications to ensure appropriate assessment and treatment.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 13


Clinical Governance<br />

All complications should be recorded and presented at regular <strong>Endoscopy</strong> Users Group meetings. This<br />

will allow review to identify any trends to be identified so that safety can be improved.<br />

Endoscopic procedure Major complication Risk<br />

Diagnostic upper <strong>GI</strong> Perforation 1 in 5000<br />

Haemorrhage < 1 in 5000<br />

Oesophageal dilatation (benign lesion) Perforation 1 in 200<br />

Oesophageal dilatation (malignant lesion) Perforation 1 in 25<br />

Achalasia balloon dilatation Perforation Up to 1 in 20<br />

Diagnostic lower <strong>GI</strong> (colonoscopy) Perforation 1 in 1500<br />

Haemorrhage 1 in 500<br />

Therapeutic lower <strong>GI</strong> polypectomy Perforation 1 in 500<br />

Haemorrhage 1 in 100<br />

Reducing the risk of endoscopic complications<br />

Assess Risk v Benefit (esp. Therapeutic procedures)<br />

Ensure appropriate preparation (assess co-morbidities, anticoagulation etc )<br />

Appropriate monitoring and use of sedation<br />

Supervision of trainees<br />

Team Culture that prioritises safety first<br />

Key Messages<br />

Diagnostic colonoscopy is generally a safe procedure. Complications may occur related to:<br />

Bowel preparation<br />

Therapeutic procedures, particularly polypectomy<br />

Abnormal diseased tissue e.g. severe colitis or acute diverticulitis<br />

Outcome of complications will be worse in the elderly with significant co-morbidity, or if the recognition<br />

of the complication is delayed<br />

On discharge patients should be given written information to explain what they should do if they have a<br />

problem after their procedure<br />

All complications should be reviewed by the endoscopy users group<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 14


Diathermy<br />

Roger Leicester, St George’s <strong>Endoscopy</strong> <strong>Training</strong> Centre<br />

Edited by Dr Paul O’Toole and Dr John Anderson<br />

How diathermy works<br />

When an electrical current passes through a conductor some of its energy appears as heat. For any given<br />

conductor, the heat generated depends upon its resistance and the density of current flow. Heat<br />

generated in tissue during the passage of a diathermy current can be used for cutting, coagulation or<br />

tissue destruction.<br />

Thermal devitalisation: Irreversible death of biological tissue. Occurs above temp 41.5⁰C. The high the<br />

temperature the faster the devitalisation. Often not a visible phenomenon and can occur outside the<br />

borders of coagulation zone (intentionally or not).<br />

Thermal Coagulation: conversion of collloidal systems from sol to gel state (e.g. boiling an egg). Temp<br />

above 60⁰C cause tissue coagulation. Associated with change of colour to tissues, formation of<br />

derivatives of collagen, contraction of collagen containing tissue. Can result in glue effect sealing tissues<br />

to each other and accessories. Colour change to tissue can be used as an indicator of area of controlled<br />

tissue devitalisation, but this is not precise.<br />

Thermal desiccation: Heat induced dehydration of tissue. Temperature is equal to boiling point of the<br />

water in tissue. (100⁰C). Desiccation causes contraction of tissue, adhesive effect and dry layer which<br />

acts to insulate tissue electrically. This can result in no cutting effect from snare mid-polypectomy with<br />

snare around tissue and unable to be disengaged.<br />

Thermal carbonisation: Partial oxidation of tissue hydrocarbon compounds if the temperature exceeds<br />

200⁰C. Can cause smoke to form and leaves tissue black.<br />

Thermal Vaporisation: Combustion of desiccated and/or carbonated tissue. Occurs above 500⁰C. Can be<br />

used for thermal ablation of tissues as well as indirectly for cutting (e.g. Nd:YAG laser).<br />

Thermal damage<br />

levels that can be<br />

induced by diathermy<br />

Mains electricity is 50 Hz and produces intense muscle and nerve activation (Faradism). Diathermy uses<br />

high frequency (Radio Frequency) current in the range of 300kHz to 3MHz which has no effect on<br />

muscles or nerves or cardiac tissue.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 15


There are two types of diathermy, monopolar and bipolar.<br />

Monopolar diathermy<br />

In monopolar diathermy, current passes between the endoscope accessory and the patient plate. As the<br />

surface area of the accessory is significantly less than that of the plate, localised heating is produced at<br />

the accessory. The large return electrode (patient plate), which completes the circuit, spreads the<br />

current over a wide area and produces little heat. The polypectomy snare and hot biopsy forceps are<br />

examples of monopolar accessories.<br />

Bipolar diathermy<br />

In bipolar diathermy, two electrodes are combined in the accessory (e.g. gold probe). Current passes<br />

through the tissue between the electrodes and not through the rest of the patient’s body. A return<br />

plate is not required.<br />

Settings<br />

The document has purposefully omitted indicating any particular settings for diathermy. Setting need to<br />

take into account the diathermy unit being used, type, size and location of tissue it is being applied on<br />

and finally the effect desired. The manufacturers recommendations and guides to settings are useful,<br />

but may also need to be modified in line with departmental guidance and individual experience. A<br />

general principle should be that the lowest settings are used to safely obtain the desired effect required.<br />

Cutting occurs when heating of cellular water occurs so rapidly that cells burst.<br />

CUT mode achieves this by delivering current in a high amplitude continuous wave, producing sparks<br />

whose heat explodes intracellular water to steam. CUT mode is activated by depressing the YELLOW<br />

pedal.<br />

Coagulation is a less violent heating effect leading to cell death by dehydration and protein<br />

denaturation. The dead tissue is shrunken and dried with distortion of blood vessel walls, coagulation of<br />

plasma proteins and stimulation of the clotting mechanism. Coagulated tissue typically appears white.<br />

COAG effect can be achieved by using a continuous waveform of low peak voltage (‘soft coagulation’) or<br />

by using current that has an interrupted (modulated) waveform with the energy delivered in short<br />

bursts (‘forced coagulation’). Combined with pressure (e.g. from a closing snare), forced coagulation<br />

current will cut through tissue. COAG is activated by depressing the BLUE pedal.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 16


Peak voltage and mean power output can be<br />

varied by adjusting the duration of current bursts<br />

and their intensity to give a combination of cutting<br />

and coagulation. This is known as ‘blended’<br />

current.<br />

More modern diathermy units incorporate<br />

‘Endocut’ (or ‘PulseCut’) which deliver pulses of<br />

cutting followed by coagulation current at<br />

predetermined powers and intervals.<br />

Many operators select this mode of operation for<br />

polypectomy. Others prefer to use bursts of forced<br />

coagulation while applying increasing tension on<br />

the snare to control the rate at which the tissue is<br />

transected. The diathermy mode should be<br />

selected by the operator after taking into account<br />

the type of lesion (flat vs pedunculated), site of lesion (stomach, duodenum, right colon, left colon) and<br />

possible risks (e.g. bleeding, perforation).<br />

Blend ‘clever cut’<br />

Cut current<br />

Coagulation current<br />

Endocut or PulseCut, (clever-cut) modes consisting or alternating bursts of cutting and coagulation<br />

currents. The time intervals between the different modes of cutting and coagulation can be varied to<br />

have more cut or more coagulation in the cycles.<br />

If using Endocut (or PulseCut), the following recommendations for safe use should be followed:<br />

Press yellow pedal continuously<br />

Gently close snare around polyp to resistance - often does not need tightening<br />

Do not ‘tap & shake’<br />

Use sub-mucosal lifting solution + adrenalin +/- dye<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 17


Power Settings<br />

Diathermy generators from different manufacturers vary widely and there is often little relationship<br />

between the output settings of one machine and another. Further variation is introduced by using<br />

snares of different wire thickness.<br />

As tissue is desiccated, its electrical resistance increases and more energy is required to cut it. Many<br />

modern units can monitor tissue impedance and adjust the current automatically - known as adaptive<br />

diathermy or ‘clever cut’.<br />

The power setting and mode of operation selected will depend on the type of procedure, tissue<br />

structure, patient’s body mass index and accessory used. As mentioned above, the aim is to use the<br />

lowest power setting possible that will accomplish the desired tissue effect.<br />

In addition to the desired cutting or coagulation, diathermy will produce a zone of thermal devitalisation<br />

beyond the visibly coagulated tissue. Subsequent necrosis of devitalised tissue can result in late<br />

perforation or bleeding. For this reason, reduced power settings are used in areas of the <strong>GI</strong> tract where<br />

the bowel wall is thin (e.g. right colon). Coagulation current usually results in a deeper heat penetration<br />

of the tissue that cut current (dependent on settings).<br />

For pedunculated polyps the main risk is of bleeding and the focus is on safe coagulation of the<br />

supplying vessel (coagulation). For sessile lesions, the risk and focus is ensuring no transmural injury<br />

occurs, therefore endoscopists favour the use of a lifting solution and cut or ‘clever-cut’.<br />

Precautions when using diathermy<br />

Endoscopic accessories<br />

The electrode wire should not be deformed, frayed, or broken. The insulation should not be<br />

cracked or have exposed metal surfaces.<br />

Do not allow metal parts of the accessory to touch the scope during operation.<br />

Patient plate<br />

A check that the patient plate has not been forgotten or become separated should be routine.<br />

The full surface of the patient plate should be in firm contact with part of the patient’s body.<br />

Areas with heavy body hair or scars should be avoided.<br />

Always use a single-use plate, preferably one which has an equipotential ring which will alarm<br />

and inhibit operation if it becomes partially detached<br />

Diathermy unit<br />

Check that the various functions of the power supply are working normally in accordance with<br />

the instruction manual before use.<br />

Check that you are able to select between cutting, coagulation and blend or ‘Endocut’ (or<br />

‘PulseCut’) modes.<br />

Check that the desired output level can be set.<br />

Check that the output can be controlled by the foot switch.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 18


Combustible gases<br />

Do not perform electrosurgery in the presence of combustible gases (such as anaesthetic gases).<br />

In locations where combustible gases may be present, such as the colon, the procedure should<br />

be preceded by replacement of the intraluminal gas with air or a carbon dioxide.<br />

Body surface protection<br />

Check that the patient’s body is not in contact with metal fittings on the bed.<br />

The operator and assistant should wear gloves.<br />

Interference with electrical equipment<br />

Diathermy has the potential to interfere with implanted cardiac pacemakers and defibrillators.<br />

Special precautions must be taken in line with local and national guidelines.<br />

Further Reading<br />

Rey, J. F.; Beilenhoff, U.; Neumann, C. S.; Dumonceau, J. M.: European Society of Gastrointestinal<br />

<strong>Endoscopy</strong> (ESGE) guideline: the use of electrosurgical units. Appendix<br />

MHRA Guidelines for the perioperative management of patients with implantable pacemakers or<br />

implantable cardioverter defibrillators, where the use of surgical diathermy/electrocautery is<br />

anticipated. (2006) http://www.mhra.gov.uk/<br />

G Farin and KE Grund. Principles of Electrosurgery, Laser, and Argon Beam Coagulation with Paricular<br />

Regard to Colonoscopy . Colonoscopy Principle and Practice 2 nd Edition, Ed Wiley-Blackwell. Section 7,<br />

pages 326-345.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 19


Endoscope Design and Function<br />

Welsh Institute for Minimal Access Therapy (WIMAT) and John Anderson<br />

Overview<br />

Head of instrument<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 20


Channels<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 21


Decontamination of <strong>GI</strong> endoscopes<br />

Rachael, Hodson, East Yorkshire <strong>Training</strong> Centre, Hull<br />

Flexible <strong>GI</strong> endoscopes are part of a range of reusable equipment in endoscopy, and require<br />

decontaminating between patients. This is in order to prevent infection, protect the quality of diagnostic<br />

samples, to prolong the life of the equipment and to protect staff. The reported frequency of endoscope<br />

transmitted infection is 1 in 1.8 million procedures. However, cases of infection or contamination are<br />

not reported and onset of infections may occur following discharge. Many infections such as VCJD have<br />

long intubation periods and people do not know they are high risk. The key National <strong>Endoscopy</strong> Team<br />

document Decontamination Standards for Flexible Endoscopes 2009 draws together all UK guidance and<br />

standards to be followed for systems and processes, workforce and training, environment and<br />

equipment and policies and processes.<br />

<strong>GI</strong> endoscopes in most units undergo high level decontamination, as they are heat sensitive and not<br />

amenable to usual methods of cost effective, easy sterilisation. This is a highly technical process and<br />

most units will be happy to take an endoscopist through the endoscope pathway to familiarise them<br />

with the whole process and associated elements. The endoscopist is responsible for the primary wiping<br />

down and flushing of a used endoscope before it is handed to the assistant. In a suitably designed area,<br />

with separate dirty, clean and storage areas, the assistant will manually clean the endoscope in a<br />

detergent solution, and brush through the channels to remove visible debris, before rinsing it in clean<br />

water. The endoscope undergoes further decontamination in an Automated Endoscope Reprocessor<br />

(AER) Channels connected to the valves and ports pump further detergent, disinfectant and water<br />

through the scope, completing a cleaning cycle.<br />

The endoscope is dried, and must be used within three hours to prevent growth of channel vegetation,<br />

or stored immediately within a locked endoscopy drying/ storage cabinet. These allow a cleaned<br />

endoscope to be stored for up to 31 days without requiring cleaning again. Endoscopes should be<br />

moved in special containers approved for the purpose e.g. lidded endoscope trays. Throughout this<br />

process, all parts, machinery and staff handling the endoscope must be tracked. This allows a look back<br />

exercise if an infection was suspected. Prions which transmit CJD and vCJD cannot be removed by any<br />

decontamination. Therefore valves must be kept as a unique set with the endoscope, and biopsy valves<br />

are replaced after a biopsy has been taken. It takes about an 45 minutes to one hour for an endoscope<br />

to go through this process fully.<br />

Wherever possible, single use accessories should be used, and any equipment suitable for sterilisation<br />

should be decontaminated in this way.<br />

An endoscopist who undertakes an out of hours service must know how to undertake primary<br />

decontamination of an endoscope, which can then be safely left for up to 24 hours before full<br />

decontamination is undertaken.<br />

Key message<br />

SWEEP: effective and safe endoscope decontamination is a combination of systems and processes,<br />

workforce, equipment and environment and policies and procedures.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 22


Potential advantages and complications of oral bowel cleansing agents<br />

Paul O’Toole, Mersey <strong>Training</strong> Centre, Liverpool<br />

Oral Bowel<br />

Cleansing Agent<br />

(OBCA)<br />

Picolax ® or<br />

Citrafleet ®<br />

(Sodium<br />

picosulphate &<br />

magnesium<br />

citrate)<br />

Citramag ®<br />

(magnesium<br />

carbonate and<br />

citric acid)<br />

Klean Prep ®<br />

(polyethylene<br />

glycol)<br />

Moviprep ®<br />

(polyethylene<br />

glycol)<br />

Fleet<br />

Phosphosoda ®<br />

(sodium<br />

phosphate)<br />

Potential<br />

advantages of<br />

this OBCA<br />

Produces the<br />

lowest watery<br />

residue:<br />

potentially<br />

advantageous<br />

for radiological<br />

investigation.<br />

Produces a low<br />

watery residue<br />

(although not<br />

as low as<br />

Picolax ® ).<br />

Less likely to<br />

cause<br />

hypovolaemia.<br />

1. Less likely to<br />

cause<br />

hypovolaemia<br />

2. Bowel<br />

preparation can<br />

be completed<br />

within 12 hrs.<br />

Tolerability and<br />

ease of use<br />

Powder is<br />

reconstituted<br />

with a low<br />

volume of<br />

water. It then<br />

arms on mixing.<br />

Powder is<br />

reconstituted<br />

with a low<br />

volume of hot<br />

water.<br />

Powder is<br />

reconstituted<br />

with a high<br />

volume of water<br />

(up to 4 litres).<br />

Powder is<br />

reconstituted<br />

with a moderate<br />

volume of water<br />

(approx 2 litres).<br />

Well tolerated. A low volume of<br />

liquid (45 mls) is<br />

mixed with a<br />

low volume of<br />

water (120 mls).<br />

Is a low<br />

residue diet<br />

advised prior<br />

to dosing?<br />

Are there complications<br />

specific to this OBCA? *<br />

Yes 1. Higher risk of<br />

hyponatraemia (if excessive<br />

water ingestion) than with<br />

other OBCA’s.<br />

2. Risk of<br />

hypermagnesaemia in<br />

patients with advanced<br />

Chronic Kidney Disease.<br />

Yes. 1. Higher risk of<br />

hyponatraemia (if excessive<br />

water ingestion) than with<br />

other OBCA’s.<br />

2. Risk of<br />

hypermagnesaemia in<br />

patients with advanced<br />

Chronic Kidney Disease.<br />

Yes. Lowest risk of provoking<br />

hypovolaemia and/or<br />

hyponatraemia.<br />

Yes. Lowest risk of provoking<br />

hypovolaemia and/or<br />

hyponatraemia.<br />

No. It is<br />

sufficient to<br />

simply avoid<br />

solid food<br />

during the<br />

dosing<br />

period.<br />

1. Acute Phosphate<br />

Nephropathy.<br />

2. Hypocalcaemia resulting<br />

from hyper-phosphataemia.<br />

3. Highest risk of<br />

hypovolaemia.<br />

Are there any<br />

contraindications specific to<br />

this OBCA? +<br />

It is particularly important<br />

that patients with conditions<br />

predisposing to<br />

hypovolaemia are evaluated<br />

prior to receiving this OBCA.<br />

It is particularly important<br />

that patients with conditions<br />

predisposing to<br />

hypovolaemia are evaluated<br />

prior to receiving this OBCA.<br />

G6PD deficiency.<br />

Should not be prescribed to<br />

patients with;<br />

1. hypovolaemia<br />

2. eGFR < 60<br />

ml/min/1.73m 2<br />

3. hepatic cirrhosis<br />

4. cardiac failure<br />

5. hypertension<br />

6. renin-angiotensin blockade<br />

…unless all other OBCA’s are<br />

contraindicated.<br />

*<br />

It should be remembered that the administration of ALL types of OBCA may be complicated by hypovolaemia and/or electrolyte disturbances (including hypokalaemia,<br />

hyponatraemia and hypernatraemia).<br />

+<br />

The following are absolute contraindications to ALL types of OBCA: gastrointestinal obstruction, perforation or ileus; acute intestinal ulceration; severe inflammatory bowel dise<br />

reduced consciousness; hypersensitivity to any of the ingredients; ileostomy.<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 23


Suggested Background reading for <strong>Basic</strong> lower <strong>GI</strong> endoscopy course<br />

John Todd, Cushieri <strong>Skills</strong> Centre, Dundee<br />

Antibiotic prophylaxis<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/prophylaxis_09.pdf<br />

Anticoagulation<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/anticoagulant_08.pdf<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/anticoagulant_flow_08.p<br />

df<br />

Consent<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/consent08.pdf<br />

Decontamination<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/decontamination_2008.<br />

pdf<br />

http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasse<br />

t/dh_123588.pdf<br />

Complications of <strong>GI</strong> endoscopy<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/complications.pdf<br />

Sedation<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/sedation.doc<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/sedation_elderly.pdf<br />

Colorectal cancer/ polyp surveillance<br />

http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/endoscopy/ccs_10.pdf<br />

Colonoscopy: Principles and Practice, 2nd Edition<br />

JD Waye, DK Rex, PB Cotton<br />

Publisher: John Wiley & Sons<br />

ISBN: 978-1-4051-7599-9<br />

Practical Gastrointestinal <strong>Endoscopy</strong>. The fundamentals. 6 th Ed.<br />

PB Cotton, CB Williams, RH Hawes, BP Saunders<br />

Publisher: John Wiley & Sons<br />

ISBN: 9781405159029<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 24


Suggested Website <strong>Resource</strong>s<br />

Paul O’Toole, Mersey <strong>Training</strong> Centre, Liverpool<br />

https://www.jets.nhs.uk/<br />

https://www.bcsp.nhs.uk/<br />

http://www.bsg.org.uk/<br />

http://www.thejag.org.uk/<br />

http://www.gmc-uk.org/<br />

http://www.cancerscreening.nhs.uk/bowel/index.html<br />

http://www.ncbi.nlm.nih.gov/pubmed/<br />

http://www.grs.nhs.uk/<br />

http://www.library.nhs.uk/gastroliver/<br />

http://www.cqc.org.uk/<br />

http://www.screenersupport.nhs.uk/<br />

http://www.esge.com/<br />

http://www.thieme-connect.com/ejournals/toc/endoscopy<br />

http://www.mdconsult.com/<br />

http://daveproject.org/<br />

http://www.gastrolab.net/<br />

http://www.asge.org/<br />

http://www.endoatlas.com/<br />

http://www.gastrohep.com<br />

http://www.gastrointestinalatlas.com/<br />

http://gut.bmjjournals.com/<br />

http://www.murrasaca.com/<br />

http://www.sign.ac.uk/<br />

http://www.nice.org.uk/<br />

http://www.nccn.org/professionals/physicians_gls/f_guidelines.asp<br />

http://www.npsa.nhs.uk<br />

http://www.ncepod.org.uk/<br />

http://gastrojournal.org/<br />

http://acpgbi.org.uk/<br />

http://augis.org/<br />

http://www.nhs.uk<br />

http://daveproject.org<br />

L<strong>GI</strong> <strong>Resource</strong> <strong>Folder</strong> JTA 2012 Page 25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!